Nuvalent (NUVL) Shares Issued (2021 - 2026)
Nuvalent (NUVL) posted Shares Issued of $7.8 million for Q1 2026, up 1.71% on a QoQ basis from $7.7 million in Q4 2025, and up 64.67% year-over-year from $4.8 million in Q1 2025.
Nuvalent (NUVL) Shares Issued (2021 - 2026) Analysis & Trends
Nuvalent's Shares Issued history runs 6 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- Quarterly Shares Issued rose 64.67% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 64.67% YoY) and the FY2025 annual result came in at $7.7 million, down 3.29% from the prior year.
- Shares Issued was $7.8 million for Q1 2026 at Nuvalent, up from $7.7 million in the prior quarter.
- Across five years, Shares Issued topped out at $8.7 million in Q2 2025 and bottomed at $4.1 million in Q2 2024.
- A 5-year average of $6.8 million and a median of $6.5 million in 2022 frame the typical range for Shares Issued.
- Peak annual rise in Shares Issued reached 111.95% in 2025, while the deepest fall reached 45.23% in 2025.
- Nuvalent's Shares Issued stood at $6.5 million in 2022, then advanced by 24.5% to $8.0 million in 2023, then slipped by 0.68% to $8.0 million in 2024, then fell by 3.29% to $7.7 million in 2025, then climbed by 1.71% to $7.8 million in 2026.
- Business Quant data shows NUVL's Shares Issued at $7.8 million in Q1 2026, $7.7 million in Q4 2025, and $8.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 88,604.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.44 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 7.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.85 Mn |
| Mar 31, 2026 | 7.85 Mn |
| Dec 31, 2025 | 7.72 Mn |
| Dec 31, 2025 | 7.72 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 7.98 Mn |
| Dec 31, 2024 | 7.98 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 8.70 Mn |
| Mar 31, 2024 | 8.70 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Dec 31, 2023 | 8.03 Mn |